Posttreatment reactivation of tuberculosis in mice caused by mycobacterium tuberculosis disrupted in mce1R

Journal of Infectious Diseases

Volumn 202, Issue 5, 2010, Pages 752-759

  Cheigh, Chan Ick ^a   Senaratne, Ryan ^a   Uchida, Yujiro ^a   Casali, Nicola ^a   Kendall, Lon V ^b   Riley, Lee W ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b Department of Ecosystem Science and Sustainability   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ISONIAZID; PYRAZINAMIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; HISTOPATHOLOGY; INFECTION RESISTANCE; LATENT TUBERCULOSIS; MCE1 GENE; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; OPERON; PRIORITY JOURNAL; RECURRENT DISEASE; TUBERCULOSIS;

ANIMALS; ANTITUBERCULAR AGENTS; BACTERIAL PROTEINS; DISEASE MODELS, ANIMAL; FEMALE; HUMANS; ISONIAZID; LUNG; MICE; MICE, INBRED BALB C; MUTATION; MYCOBACTERIUM TUBERCULOSIS; OPERON; PYRAZINAMIDE; TIME FACTORS; TUBERCULOSIS, PULMONARY;

EID: 77955671543     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/655224     Document Type: Article

References (28)

1. Dye C, Scheele S, Dolin P, Pathania V, Raviglione MC. Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance andMonitoring Project. JAMA 1999; 282:677-686.
2. Parrish NM, Dick JD, Bishai WR. Mechanisms of latency in Mycobacterium tuberculosis. Trends Microbiol 1998; 6:107-112.
3. Raviglione MC, Snider DE Jr, Kochi A. Global epidemiology of tuberculosis: morbidity and mortality of a worldwide epidemic. JAMA 1995; 273:220-226.
4. Chiang CY, Riley LW. Exogenous reinfection in tuberculosis. Lancet Infect Dis 2005; 5:629-636.
5. Adams LB, Mason CM, Kolls JK, Scollard D, Krahenbuhl JL, Nelson S. Exacerbation of acute and chronic murine tuberculosis by administration of a tumor necrosis factor receptor-expressing adenovirus. J Infect Dis 1995; 171:400-405.
6. Flynn JL, Scanga CA, Tanaka KE, Chan J. Effects of aminoguanidine on latent murine tuberculosis. J Immunol 1998; 160:1796-1803.
7. Orme IM. A mouse model of the recrudescence of latent tuberculosis in the elderly. Am Rev Respir Dis 1988; 137:716-718.
8. Scanga CA, Mohan VP, Joseph H, Yu K, Chan J, Flynn JL. Reactivation of latent tuberculosis: variations on the Cornell murine model. Infect Immun 1999; 67:4531-4538.
9. Mohan VP, Scanga CA, Yu K, et al. Effects of tumor necrosis factor alpha on host immune response in chronic persistent tuberculosis: possible role for limiting pathology. Infect Immun 2001; 69:1847-1855.
10. Rhoades ER, Frank AA, Orme IM. Progression of chronic pulmonary tuberculosis in mice aerogenically infected with virulentMycobacterium tuberculosis. Tuber Lung Dis 1997; 78:57-66.
11. McCune RM, Tompsett R. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. I. The persistence of drug-susceptible tubercle bacilli despite prolonged antimicrobial therapy. J Exp Med 1957; 104:737-762.
12. McCune RM, Tompsett R, McDermott W. Fate of Mycobacterium tuberculosis in mouse tissues as determined by the microbial enumeration technique. II. The conversion of tuberculous infection to the latent state by the administration of pyrazinamide and a companion drug. J Exp Med 1957; 104:763-802.
13. McCune RM, Feldmann FM, Lambert HP, McDermott W. Microbial persistence. I. The capacity of tubercle bacilli to survive sterilization in mouse tissues. J Exp Med 1966; 123:445-468.
14. McCune RM, Feldmann FM, McDermott W. Microbial persistence. II. Characteristics of the sterile state of tubercle bacilli. J Exp Med 1966; 123:469-486.
15. Cole ST, Brosch R, Parkhill J, et al. Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence. Nature 1998; 393:537-544.
16. Casali N, Riley LW. A phylogenomic analysis of the Actinomycetales mce operons. BMC Genomics 2007; 8:60-82.
17. Shimono N, Morici L, Casali N, et al. Hypervirulent mutant of Mycobacterium tuberculosis resulting from disruption of the mce1 operon. Proc Natl Acad Sci U S A 2003; 100:15918-15923.
18. Casali N, White AM, Riley LW. Regulation of the Mycobacterium tuberculosis mce1 operon. J Bacteriol 2006; 188:441-449.
19. Uchida Y, Casali N, White A, Morici L, Kendall LV, Riley LW. Accelerated immunopathological response of mice infected with Mycobacterium tuberculosis disrupted in the mce1 operon negative transcriptional regulator. Cell Microbiol 2007; 9:1275-1283.
20. Parish T, Stoker NG. Use of a flexible cassette method to generate a double unmarked Mycobacterium tuberculosis tlyA plcABC mutant by gene replacement. Microbiology 2000; 146:1969-1975.
21. Senaratne RH, De Silva AD, Williams SJ, et al. 5'- Adenosinephosphosulphate reductase (CysH) protects Mycobacterium tuberculosis against free radicals during chronic infection phase in mice. Mol Microbiol 2006; 59:1744-1753.
22. Lima P, Sidders B, Morici L, et al. Enhanced mortality despite control of lung infection in mice aerogenically infected with a Mycobacterium tuberculosis mce1 operon mutant. Microbes Infect 2007; 9:1285-1290.
23. Dassa E, Bouige P. The ABC of ABCS: a phylogenetic and functional classification of ABC systems in living organisms. Res Microbiol 2001; 152:211-229.
24. Joshi SM, Pandey AK, Capite N, Fortune SM, Rubin EJ, Sassetti CM. Characterization of mycobacterial virulence genes through genetic interaction mapping. Proc Natl Acad Sci U S A 2006; 103:11760-11765.
25. Dunphy K, Senaratne RH, Masuzawa M, Kendall LV, Riley LW. Attenuation of Mycobacterium tuberculosis functionally disrupted in a fatty acyl-CoA synthetase gene fadD5. J Infect Dis 2010; 201:1232-1239.
26. DiRusso CC, Black PN. Bacterial long chain fatty acid transport: gateway to a fatty acid-responsive signaling system. J Biol Chem 2004; 279: 49563-49566.
27. Pandey AK, Sassetti CM. Mycobacterial persistence requires the utilization of host cholesterol. Proc Natl Acad Sci U S A 2008; 105:4376-4380.
28. Beste DJ, Espasa M, Bonde B, Kierzek AM, Stewart GR, McFadden J. The genetic requirements for fast and slow growth in mycobacteria. PLoS One 2009; 4:e5349.